- Pure Extracts (PULL) sells its first shipment of cannabis oil extracts to a German pharma company
- These extracts will be further processed in Germany into an ultra-pure form of THC for medicinal purposes
- Pure Extracts features a state-of-the-art processing facility located 20 minutes north of Whistler, British Columbia
- On September 25, 2020, Pure Extracts was granted its Standard Processing License by Health Canada under the Cannabis Act
- Pure Extracts (PULL) is up 5.88 per cent and is trading at C$0.54 at 11:04 am EST
Pure Extracts (PULL) is a plant-based extraction company focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector.
Pure Extracts has sold its first batch of cannabis oil extracts to a German pharmaceutical company.
Pure Extracts purchased Canadian grown, EU-GMP certified, dry cannabis flower and extracted it into 65 per cent pure THC full spectrum oil (FSO) and 85 per cent pure THC distillate.
These extracts will be further processed in Germany into an ultra-pure form of THC for medicinal purposes.
This initial sale will pave the way for longer-term supply agreements into Germany, Europe’s most important market, and Pure Extracts plans to continue seeking export opportunities for its products in other European countries wherever cannabis can legally sell them.
Pure Extracts CEO, Ben Nikolaevsky, remarked,
“It is gratifying to have had our concentrates selected by a German pharmaceutical company for use in their medical products.
“We are excited about the entire European market opportunity for our extracts,” added Nikolaevsky.
Pure Extracts features a state-of-the-art processing facility located 20 minutes north of Whistler, British Columbia.
The processing facility has been constructed to European Union GMP standards aiming towards export sales of products and formulations, including those currently restricted in Canada, into European jurisdictions where they are legally available.
On September 25, 2020, Pure Extracts was granted its Standard Processing License by Health Canada under the Cannabis Act, and its stock began trading on the Canadian Securities Exchange (CSE) on November 5, 2020.
Pure Extracts (PULL) is up 5.88 per cent and is trading at C$0.54 at 11:04 am EST.
